ClinicalTrialsFinder

Recurrent Lung Non-Squamous Non-Small Cell Carcinoma Clinical Trials in Philadelphia, Pennsylvania

1 recruitingPhiladelphia, Pennsylvania

Showing 1–1 of 1 trials

Recruiting
Phase 3

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Stage IIIB Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8Advanced Lung Non-Squamous Non-Small Cell Carcinoma+2 more
National Cancer Institute (NCI)300 enrolled604 locationsNCT04181060